PATENT CLAIM ANALYSIS

Application Number: 15780289
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "210180"]

Abstract:
In its many embodiments, the present invention provides certain substituted bispiperidinyl compounds of the Formula (I): and pharmaceutically acceptable salts thereof, wherein ring A, ring B, R 1 , R 2 , R 3 , L, R 4 , X, Z, Li, Q and R5 are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

Claim (Index 9):
The compound according to  claim 1 , or a pharmaceutically acceptable salt thereof, said compound selected from the group consisting of:

Metadata:
- Claim Count in Document: 23.0
- Percentile: 93.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15774157', '14721262', '15204422', '14657179', '15182749']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7980704635417303
- 35 USC 102 Novelty (BERT): 0.5770925350405439
- Combined Prediction Score: 0.7759726706916117
- Mean Citation Score: 351.86578
- Max Citation Score: 468.0021
- Similarity Product: 399.6934186063169

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test